Vanguard Global Advisers’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.24M Buy
899,317
+43,617
+5% +$252K ﹤0.01% 769
2026
Q2
$4.22M Buy
855,700
+59,864
+8% +$321K ﹤0.01% 855
2026
Q1
$4.3M Buy
+795,836
New +$4.76M ﹤0.01% 817

Other funds holding BHC

Vanguard Global Advisers's BHC Position: Q3 2026 in Review

Vanguard Global Advisers increased its Bausch Health (BHC) stake by 5.1% in Q3 2026, buying an estimated $252K and bringing the position to 899,317 shares worth $5.24M. The position accounts for ﹤0.01% of the portfolio, ranked #769.

Vanguard Global Advisers first reported a position in BHC in Q1 2026 and has held it in 3 quarters since. 232 funds tracked by Wall St. Rank hold BHC as of Q3 2026.

  • Vanguard Global Advisers held 899,317 shares of Bausch Health worth $5.24M as of Q3 2026.
  • Vanguard Global Advisers bought 43,617 Bausch Health shares in Q3 2026, an estimated $252K.
  • Bausch Health made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #769 holding.
  • Vanguard Global Advisers first reported a position in Bausch Health in Q1 2026 and has held it in 3 quarters since.
  • 232 funds tracked by Wall St. Rank held Bausch Health as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.